Immunovant IMVT Balance Sheet (2018-2026)

NASDAQ IMVT
$39.03 -0.08 (-0.22%)
As of: Sep 4, 2026 · 12:49 PM EDT
Reported Financials

Immunovant Quarterly Balance Sheet

Periods 31 quarters
Latest Jun 2026

Immunovant reported total assets of $852.49M and total liabilities of $117.10M for the quarter ended Jun 2026, up 28.9% year over year. This balance sheet covers 31 quarters of results from Dec 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
559.00M527.00M493.82M427.20M405.80M432.61M376.53M330.00M269.93M690.94M635.37M560.00M472.94M374.70M713.97M598.91M521.90M994.52M902.11M797.80M
Receivables - NetNet Receivables
12.23M13.18M3.78M0.70M0.70M0.82M1.42M1.03M5.34M2.42M1.88M2.22M2.08M1.94M1.97M1.64M1.13M0.70M
Receivables
12.23M13.18M3.78M0.70M0.70M0.82M1.42M1.03M5.34M2.42M1.88M2.22M2.08M1.94M1.97M1.64M1.13M0.70M
Prepaid Assets
4.84M13.48M6.25M15.92M16.54M21.11M26.92M19.23M19.83M18.81M24.90M26.62M32.55M35.63M51.18M50.91M49.71M46.77M45.58M52.68M
Current Assets
563.79M540.48M512.93M456.30M426.09M454.42M404.33M350.01M291.18M710.78M665.77M589.05M507.37M412.54M767.66M651.76M573.55M1,042.94M948.82M851.18M
Non-Current Assets
Property, Plant & Equipment (Net)
0.21M0.25M0.33M0.33M0.31M0.36M0.33M0.33M0.30M0.38M0.46M0.56M0.67M0.75M0.84M0.74M0.63M0.53M0.44M0.35M
Long-Term Investments
Long-Term Deferred Tax
Other Non-Current Assets
7.62M7.62M7.62M8.94M8.78M8.92M7.75M0.96M
Non-Current Assets
2.94M2.70M2.63M2.35M2.06M1.82M1.50M1.21M0.89M0.67M0.59M0.63M8.34M8.39M8.56M9.68M9.41M9.45M8.20M1.31M
Assets
566.73M543.18M515.56M458.66M428.15M456.24M405.84M351.22M292.07M711.45M666.37M589.68M515.71M420.93M776.22M661.44M582.96M1,052.39M957.01M852.49M
Liabilities
Current Liabilities
Accounts Payables
4.24M3.83M18.63M1.07M7.46M14.00M1.35M26.46M7.51M3.91M7.16M11.04M20.73M19.82M17.66M7.84M6.92M8.62M7.54M10.14M
Notes Payables
0.17M0.35M
Payables
4.24M3.83M18.80M1.07M7.46M14.00M1.70M26.46M7.51M3.91M7.16M11.04M20.73M19.82M17.66M7.84M6.92M8.62M7.54M10.14M
Accumulated Expenses
23.06M31.45M24.57M19.01M23.14M26.05M40.42M23.98M32.13M27.89M41.30M33.91M45.88M48.48M50.75M45.06M56.34M57.64M96.88M106.96M
Other Accumulated Expenses
0.35M0.01M0.27M0.17M
Current Leases
1.08M1.08M1.15M1.17M1.19M1.21M1.17M0.92M0.61M0.31M0.14M0.07M0.05M0.02M0.10M0.07M
Current Taxes
Total Current Liabilities
28.38M36.35M44.52M21.24M31.78M41.26M43.30M51.36M40.26M32.10M48.61M45.02M66.65M68.31M68.78M52.90M63.25M66.26M104.42M117.10M
Non-Current Liabilities
Non-Current Deffered Revenue
Preferred Stock Liabilities
Operating Leases
1.95M1.68M1.22M0.92M0.61M0.31M0.05M0.14M
Total Liabilities
30.34M38.03M45.74M22.16M32.40M41.56M43.34M51.36M40.26M32.10M48.61M45.02M66.65M68.31M68.78M52.90M63.25M66.26M104.42M117.10M
Shareholder's Equity
Total Debt
0.17M0.35M
Common Equity
536.40M505.15M469.82M436.49M395.75M414.68M362.49M299.87M251.81M679.34M617.76M544.66M449.05M352.62M707.45M608.54M519.71M986.13M852.59M735.39M
Liabilities and Shareholders Equity
566.73M543.18M515.56M458.66M428.15M456.24M405.84M351.22M292.07M711.45M666.37M589.68M515.71M420.93M776.22M661.44M582.96M1,052.39M957.01M852.49M
Retained Earnings
802.77M812.93M824.80M832.50M840.66M920.20M927.98M939.55M950.23M1,430.29M1,441.52M1,455.66M1,469.08M1,483.20M1,945.49M1,966.92M2,004.88M2,582.19M2,596.97M2,633.00M